Cognitive status doesn't impact cortical A-beta, tau in Parkinson's

December 12, 2017

(HealthDay)—Patterns of cortical β-amyloid (Aβ) and tau are not different for patients with Parkinson's disease (PD) who are cognitively normal (PD-CN) or with mild cognitive impairment (MCI) and for healthy adults, according to a study published online Dec. 11 in JAMA Neurology.

Joseph R. Winer, from the University of California in Berkeley, and colleagues conducted a cross-sectional study involving 29 patients with PD (15 with PD-CN and 14 with PD-MCI) and 49 healthy controls to compare tau positron emission tomographic (PET) measurements.

The researchers found that six PD patients were Aβ-positive, of whom one had PD-MCI, and 23 patients were Aβ-negative. There were no significant differences in voxel-wise contrasts of whole-brain tau PET uptake between patients with PD-CN and PD-MCI, or for all patients with PD versus Aβ-negative controls. There were no differences in tau PET binding between patients with PD-MCI and PC-CN in reflecting Alzheimer's disease Braak stages 1/2, 3/4, or 5/6, nor was there any difference from Aβ-negative healthy older adults. In Aβ-positive patients with PD there was significantly elevated tau PET binding relative to Aβ-negative patients with PD within brain regions reflecting Alzheimer's disease Braak stage 3/4 and Braak stage 5/6.

"Age, Aβ, and tau do not differentiate with PD-CN and PD-MCI," the authors write. "Cognitive deficits in people with PD without dementia do not appear to reflect measureable Alzheimer disease."

Two authors disclosed financial ties to the pharmaceutical industry; Avid Radiopharmaceuticals enabled use of the [18F] AV-1451 tracer.

Explore further: Memory scores limited as Alzheimer's screening tool

More information: Abstract/Full Text

Related Stories

Memory scores limited as Alzheimer's screening tool

December 4, 2017
(HealthDay)—Low memory scores are an early marker of amyloid positivity, but have limited value as a screening measure for early Alzheimer's disease among persons without dementia, according to a study published online ...

Being unaware of memory loss predicts Alzheimer's disease, new study shows

October 10, 2017
While memory loss is an early symptom of Alzheimer's disease, its presence doesn't mean a person will develop dementia. A new study at the Centre for Addiction and Mental Health (CAMH) has found a clinically useful way to ...

Using tau imaging as diagnostic marker for Alzheimer disease

July 25, 2016
The accumulation of β-Amyloid (Αβ) and tau proteins in the brain is hallmark pathology for Alzheimer disease. Recently developed positron emission tomography (PET) tracers, including [18F]-AV-1451, bind to tau in neurofibrillary ...

Reduced corneal nerve fiber density in patients with HIV

June 12, 2017
(HealthDay)—Patients with HIV and HIV-associated sensory neuropathy (HIV-SN) have reduced corneal nerve fiber density, which can be identified using in vivo corneal confocal microscopy (IVCCM), according to a study published ...

Subjective cognitive decline linked to global tau burden

October 3, 2017
(HealthDay)—For clinically healthy older adults, subjective cognitive decline (SCD) is associated with increasing entorhinal cortical tau burden and β-amyloid (Aβ) burden, according to a study published online Oct. 2 ...

More amyloid in the brain, more cognitive decline

June 14, 2017
A new study from the Center for Vital Longevity at The University of Texas at Dallas has found that the amount of amyloid plaques in a person's brain predicts the rate at which his or her cognition will decline in the next ...

Recommended for you

New evidence sheds light on how Parkinson's disease may happen

June 14, 2018
Researchers at Baylor College of Medicine and Texas Children's Hospital have identified unexpected new key players in the development of an early onset form of Parkinson's disease called Parkinsonism. These key players are ...

Scientists unravel molecular mechanisms of Parkinson's disease

June 12, 2018
Detailed brain cell analysis has helped researchers uncover new mechanisms thought to underlie Parkinson's disease.

First photoactive drug to fight Parkinson's disease

June 8, 2018
An international team has designed the first potentially therapeutic photoactive drug, MRS7145, to fight Parkinson's disease, according to the new article in Journal of Controlled Release.

Researchers address sleep problems in Parkinson's disease

June 7, 2018
A team of researchers at VIB and KU Leuven has uncovered why people with a hereditary form of Parkinson's disease suffer from sleep disturbances. The molecular mechanisms uncovered in fruit flies and human stem cells also ...

Drugs that suppress immune system may protect against Parkinson's

May 31, 2018
People who take drugs that suppress the immune system are less likely to develop Parkinson's disease, according to a study from Washington University School of Medicine in St. Louis.

Early synaptic dysfunction found in Parkinson's Disease

May 24, 2018
Northwestern Medicine scientists identified a cellular mechanism that leads to neurodegeneration in patients with Parkinson's disease, according to a study published in Proceedings of the National Academy of Sciences.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.